RCEL
AVITA Medical, Inc.Company with tickers: RCEL, AVHHL
CIK
1762303
CUSIP
05380C102
Shares Outstanding
30,776,689
Website
https://www.asx.com.au
Investor Relations
https://www.asx.com.au/investors
13F Activity (30d)
28 filings
27 filers
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Cary Vance | Director | Appointed | 2026-06-04 |
| Joseph Woody | Director | Appointed | 2026-06-04 |
| Dr. Michael Tarnoff | Director | Appointed | 2026-06-04 |
| Robert McNamara | Director | Appointed | 2026-06-04 |
| Jeremy Curnock Cook | Director | Appointed | 2026-06-04 |
| Professor Suzanne Crowe | Director | Appointed | 2026-06-04 |
| Jan Stern Reed | Director | Appointed | 2026-06-04 |